Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
PaperCitations, authors & open-access status
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 508 citations, 2018 year and closed oa status.
508
Citations
2018
Year
closed
OA Status